MTOR and B-cell chronic lymphocytic leukemia: Furthermore, phosphatidylinositol-3-kinase (PI3K)/mTOR dual inhibiton in primary CLL cells was found to induce caspase-dependent apoptosis thus representing a powerful approach for treatment of CLL [39].